Kenneth J. Kelley, Director at HALOZYME THERAPEUTICS, INC. (HALO), sold 5,000 shares at $45.00 ($225K) on 2021-04-14, disclosed to the SEC on 2021-04-14.
Open-market sale of $225k HALO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| HALO | SELL | 2021-01-04 | $417K | — | Filing → |
| HALO | SELL | 2020-12-07 | $1.4M | — | Filing → |
| HALO | SELL | 2020-12-02 | $1.3M | — | Filing → |